March 24, 2008 – Doctors implanted the first CryoValve SG pulmonary human heart valve in a patient at St. Louis Children’s Hospital in St. Louis, MO, a device used for patients who have undergone pulmonary valve replacement surgery at a young age and may require another pulmonary valve replacement in adulthood.
The CryoValve SG is processed with SynerGraft technology, which is said to remove allogeneic donor cells and cellular remnants from the valve without compromising the integrity of the underlying collagen matrix.